Letter: Adropin as a Novel Biomarker of Endothelial Dysfunction in Patients With Preeclampsia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter: Adropin as a Novel Biomarker of Endothelial Dysfunction in Patients With Preeclampsia

Published:2024-02-22 Issue:8 Volume:75 Page:800-801
ISSN:0003-3197
Container-title:Angiology
language:en
Short-container-title:Angiology

Author:

Liu Xiaocong¹,Zhang Yanan¹,Li Yan²,Lv Cuiping³^ORCID

Affiliation:

1. Department of Clinical Laboratory, Zibo Central Hospital, Zibo, China

2. Department of Clinical Laboratory, Zibo Occupational Disease Prevention and Control Hospital, Zibo, China

3. Department of Jahwa ward, Liaocheng Dongchangfu District Maternal and Child Health Hospital, Liaocheng, China

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/00033197241235757

Reference8 articles.

1. The Systemic Immune-Inflammation Index and Predicting Cardiac Implantable Electronic Device Infections

2. The relationship between maternal and umbilical cord adropin levels with the presence and severity of preeclampsia

3. Alteration of serum adropin level in preeclampsia

4. Adipokine, adropin and endothelin-1 levels in intrauterine growth restricted neonates and their mothers

5. Adropin concentrations in term pregnancies with normal, restricted and increased fetal growth

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP